Trending in Cardiovascular: TMVR, aficamten, EP robotics and more
Автор: LucidQuest
Загружено: 2026-01-16
Просмотров: 8
Описание: Here’s your Cardiovascular brief. Edwards Sapien M3 gains first US transseptal TMVR approval for inoperable MR, enabling percutaneous therapy. Cytokinetics’ Myqorzo, aficamten, is approved for obstructive HCM with a flexible REMS. Stereotaxis receives clearance for the Magic robotic ablation catheter. Acesion starts Phase 2 of oral SK channel inhibitor AP31969 in atrial fibrillation. PROTECT treats its first CABG patient with TIMP 3 gene therapy. YorLabs reports clinical use of its zero CapEx ICE system. JACC trends and ARPA H ADVOCATE spotlight scalable AI care.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: